Bogle Investment Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-88,816
Closed -$3.29M 337
2017
Q3
$3.29M Buy
88,816
+6,277
+8% +$236K 0.22% 130
2017
Q2
$3.06M Buy
82,539
+55,720
+208% +$1.82M 0.22% 127
2017
Q1
$753K Buy
+26,819
New +$757K 0.05% 246
2015
Q4
Sell
-25,947
Closed -$820K 431
2015
Q3
$820K Sell
25,947
-41,385
-61% -$1.51M 0.06% 276
2015
Q2
$2.62M Buy
+67,332
New +$2.32M 0.2% 149
2014
Q4
Sell
-29,260
Closed -$655K 400
2014
Q3
$655K Sell
29,260
-38,357
-57% -$768K 0.04% 276
2014
Q2
$1.48M Buy
+67,617
New +$1.29M 0.1% 208

Other funds holding PAHC

Bogle Investment Management's PAHC Position: Q4 2017 in Review

Bogle Investment Management sold out of Phibro Animal Health (PAHC) in Q4 2017, closing a stake of 88,816 shares — an estimated $3.29M sold.

Bogle Investment Management first reported a position in PAHC in Q2 2014 and held it in 7 quarters. The position peaked at $3.29M in Q3 2017. 169 funds tracked by Wall St. Rank hold PAHC as of Q4 2017.

  • Bogle Investment Management reported no remaining Phibro Animal Health position as of Q4 2017 after selling out during the quarter.
  • Bogle Investment Management sold 88,816 Phibro Animal Health shares in Q4 2017, an estimated $3.29M.
  • Bogle Investment Management first reported a position in Phibro Animal Health in Q2 2014 and held it in 7 quarters.
  • Bogle Investment Management's Phibro Animal Health position peaked at $3.29M in Q3 2017.
  • 169 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2017.

Based on Bogle Investment Management's 13F filing for Q4 2017, filed 13 Feb 2018.